 | • レポートコード：MRC2Q12-18945 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、臨床試験資料のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 臨床試験資料のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 臨床試験資料の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 臨床試験資料のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの臨床試験資料の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の臨床試験資料の売上および2028年までの予測に焦点を当てています。 臨床試験資料のグローバル主要企業には、Thermo Fisher Scientific、Marken、Catalent、Eurofins Scientific、Biocair、Almac Group、Piramal Pharma Solutions、Parexel、PRA Health Sciences、PCI Pharma Services、Capsugel、OCT Group、Acnos Pharma、KLIFO、Ancillare, LP、ADAllen Pharma、Recipharm、Moviantoなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 臨床試験資料市場は、タイプとアプリケーションによって区分されます。世界の臨床試験資料市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 低分子、生物製剤、医療機器 【アプリケーション別セグメント】 腫瘍学、CNS、循環器疾患、消化器疾患、免疫学、血液疾患、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 臨床試験資料製品概要 - タイプ別市場（低分子、生物製剤、医療機器） - アプリケーション別市場（腫瘍学、CNS、循環器疾患、消化器疾患、免疫学、血液疾患、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の臨床試験資料販売量予測2017-2028 - 世界の臨床試験資料売上予測2017-2028 - 臨床試験資料の地域別販売量 - 臨床試験資料の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別臨床試験資料販売量 - 主要メーカー別臨床試験資料売上 - 主要メーカー別臨床試験資料価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（低分子、生物製剤、医療機器） - 臨床試験資料のタイプ別販売量 - 臨床試験資料のタイプ別売上 - 臨床試験資料のタイプ別価格 ・アプリケーション別市場規模（腫瘍学、CNS、循環器疾患、消化器疾患、免疫学、血液疾患、その他） - 臨床試験資料のアプリケーション別販売量 - 臨床試験資料のアプリケーション別売上 - 臨床試験資料のアプリケーション別価格 ・北米市場 - 北米の臨床試験資料市場規模（タイプ別、アプリケーション別） - 主要国別の臨床試験資料市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの臨床試験資料市場規模（タイプ別、アプリケーション別） - 主要国別の臨床試験資料市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の臨床試験資料市場規模（タイプ別、アプリケーション別） - 主要国別の臨床試験資料市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の臨床試験資料市場規模（タイプ別、アプリケーション別） - 主要国別の臨床試験資料市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの臨床試験資料市場規模（タイプ別、アプリケーション別） - 主要国別の臨床試験資料市場規模（トルコ、サウジアラビア） ・企業情報 Thermo Fisher Scientific、Marken、Catalent、Eurofins Scientific、Biocair、Almac Group、Piramal Pharma Solutions、Parexel、PRA Health Sciences、PCI Pharma Services、Capsugel、OCT Group、Acnos Pharma、KLIFO、Ancillare, LP、ADAllen Pharma、Recipharm、Movianto ・産業チェーン及び販売チャネル分析 - 臨床試験資料の産業チェーン分析 - 臨床試験資料の原材料 - 臨床試験資料の生産プロセス - 臨床試験資料の販売及びマーケティング - 臨床試験資料の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 臨床試験資料の産業動向 - 臨床試験資料のマーケットドライバー - 臨床試験資料の課題 - 臨床試験資料の阻害要因 ・主な調査結果 |
Clinical Trial Material means any raw materials, parts, or supplies used in the ordinary course of development of a Product for which regulatory approval has not yet been obtained and that are used exclusively for purposes of supporting clinical and preclinical research.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Clinical Trial Material estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Clinical Trial Material is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Clinical Trial Material is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Clinical Trial Material is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Clinical Trial Material include Thermo Fisher Scientific, Marken, Catalent, Eurofins Scientific, Biocair, Almac Group, Piramal Pharma Solutions, Parexel and PRA Health Sciences, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Clinical Trial Material companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Clinical Trial Material market. Further, it explains the major drivers and regional dynamics of the global Clinical Trial Material market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Thermo Fisher Scientific
Marken
Catalent
Eurofins Scientific
Biocair
Almac Group
Piramal Pharma Solutions
Parexel
PRA Health Sciences
PCI Pharma Services
Capsugel
OCT Group
Acnos Pharma
KLIFO
Ancillare, LP
ADAllen Pharma
Recipharm
Movianto
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Clinical Trial Material Segment by Type
Small-molecules
Biologic Drugs
Medical Devices
Clinical Trial Material Segment by Application
Oncology
CNS
Cardiovascular Diseases
Digestive Disorders
Immunology
Blood Disorders
Other
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Clinical Trial Material market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Clinical Trial Material market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Clinical Trial Material, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Clinical Trial Material, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Clinical Trial Material revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Clinical Trial Material market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Clinical Trial Material revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Thermo Fisher Scientific, Marken, Catalent, Eurofins Scientific, Biocair, Almac Group, Piramal Pharma Solutions, Parexel and PRA Health Sciences, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Clinical Trial Material in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Clinical Trial Material companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Clinical Trial Material revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Trial Material Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Small-molecules
1.2.3 Biologic Drugs
1.2.4 Medical Devices
1.3 Market by Application
1.3.1 Global Clinical Trial Material Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Oncology
1.3.3 CNS
1.3.4 Cardiovascular Diseases
1.3.5 Digestive Disorders
1.3.6 Immunology
1.3.7 Blood Disorders
1.3.8 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Clinical Trial Material Market Perspective (2017-2028)
2.2 Clinical Trial Material Growth Trends by Region
2.2.1 Clinical Trial Material Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Clinical Trial Material Historic Market Size by Region (2017-2022)
2.2.3 Clinical Trial Material Forecasted Market Size by Region (2023-2028)
2.3 Clinical Trial Material Market Dynamics
2.3.1 Clinical Trial Material Industry Trends
2.3.2 Clinical Trial Material Market Drivers
2.3.3 Clinical Trial Material Market Challenges
2.3.4 Clinical Trial Material Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical Trial Material Players by Revenue
3.1.1 Global Top Clinical Trial Material Players by Revenue (2017-2022)
3.1.2 Global Clinical Trial Material Revenue Market Share by Players (2017-2022)
3.2 Global Clinical Trial Material Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Clinical Trial Material Revenue
3.4 Global Clinical Trial Material Market Concentration Ratio
3.4.1 Global Clinical Trial Material Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Trial Material Revenue in 2021
3.5 Clinical Trial Material Key Players Head office and Area Served
3.6 Key Players Clinical Trial Material Product Solution and Service
3.7 Date of Enter into Clinical Trial Material Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Trial Material Breakdown Data by Type
4.1 Global Clinical Trial Material Historic Market Size by Type (2017-2022)
4.2 Global Clinical Trial Material Forecasted Market Size by Type (2023-2028)
5 Clinical Trial Material Breakdown Data by Application
5.1 Global Clinical Trial Material Historic Market Size by Application (2017-2022)
5.2 Global Clinical Trial Material Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Clinical Trial Material Market Size (2017-2028)
6.2 North America Clinical Trial Material Market Size by Type
6.2.1 North America Clinical Trial Material Market Size by Type (2017-2022)
6.2.2 North America Clinical Trial Material Market Size by Type (2023-2028)
6.2.3 North America Clinical Trial Material Market Share by Type (2017-2028)
6.3 North America Clinical Trial Material Market Size by Application
6.3.1 North America Clinical Trial Material Market Size by Application (2017-2022)
6.3.2 North America Clinical Trial Material Market Size by Application (2023-2028)
6.3.3 North America Clinical Trial Material Market Share by Application (2017-2028)
6.4 North America Clinical Trial Material Market Size by Country
6.4.1 North America Clinical Trial Material Market Size by Country (2017-2022)
6.4.2 North America Clinical Trial Material Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Clinical Trial Material Market Size (2017-2028)
7.2 Europe Clinical Trial Material Market Size by Type
7.2.1 Europe Clinical Trial Material Market Size by Type (2017-2022)
7.2.2 Europe Clinical Trial Material Market Size by Type (2023-2028)
7.2.3 Europe Clinical Trial Material Market Share by Type (2017-2028)
7.3 Europe Clinical Trial Material Market Size by Application
7.3.1 Europe Clinical Trial Material Market Size by Application (2017-2022)
7.3.2 Europe Clinical Trial Material Market Size by Application (2023-2028)
7.3.3 Europe Clinical Trial Material Market Share by Application (2017-2028)
7.4 Europe Clinical Trial Material Market Size by Country
7.4.1 Europe Clinical Trial Material Market Size by Country (2017-2022)
7.4.2 Europe Clinical Trial Material Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Clinical Trial Material Market Size (2017-2028)
8.2 Asia-Pacific Clinical Trial Material Market Size by Type
8.2.1 Asia-Pacific Clinical Trial Material Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Clinical Trial Material Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Clinical Trial Material Market Share by Type (2017-2028)
8.3 Asia-Pacific Clinical Trial Material Market Size by Application
8.3.1 Asia-Pacific Clinical Trial Material Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Clinical Trial Material Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Clinical Trial Material Market Share by Application (2017-2028)
8.4 Asia-Pacific Clinical Trial Material Market Size by Region
8.4.1 Asia-Pacific Clinical Trial Material Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Clinical Trial Material Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Clinical Trial Material Market Size (2017-2028)
9.2 Latin America Clinical Trial Material Market Size by Type
9.2.1 Latin America Clinical Trial Material Market Size by Type (2017-2022)
9.2.2 Latin America Clinical Trial Material Market Size by Type (2023-2028)
9.2.3 Latin America Clinical Trial Material Market Share by Type (2017-2028)
9.3 Latin America Clinical Trial Material Market Size by Application
9.3.1 Latin America Clinical Trial Material Market Size by Application (2017-2022)
9.3.2 Latin America Clinical Trial Material Market Size by Application (2023-2028)
9.3.3 Latin America Clinical Trial Material Market Share by Application (2017-2028)
9.4 Latin America Clinical Trial Material Market Size by Country
9.4.1 Latin America Clinical Trial Material Market Size by Country (2017-2022)
9.4.2 Latin America Clinical Trial Material Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical Trial Material Market Size (2017-2028)
10.2 Middle East & Africa Clinical Trial Material Market Size by Type
10.2.1 Middle East & Africa Clinical Trial Material Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Clinical Trial Material Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Clinical Trial Material Market Share by Type (2017-2028)
10.3 Middle East & Africa Clinical Trial Material Market Size by Application
10.3.1 Middle East & Africa Clinical Trial Material Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Clinical Trial Material Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Clinical Trial Material Market Share by Application (2017-2028)
10.4 Middle East & Africa Clinical Trial Material Market Size by Country
10.4.1 Middle East & Africa Clinical Trial Material Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Clinical Trial Material Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Clinical Trial Material Introduction
11.1.4 Thermo Fisher Scientific Revenue in Clinical Trial Material Business (2017-2022)
11.1.5 Thermo Fisher Scientific Recent Developments
11.2 Marken
11.2.1 Marken Company Details
11.2.2 Marken Business Overview
11.2.3 Marken Clinical Trial Material Introduction
11.2.4 Marken Revenue in Clinical Trial Material Business (2017-2022)
11.2.5 Marken Recent Developments
11.3 Catalent
11.3.1 Catalent Company Details
11.3.2 Catalent Business Overview
11.3.3 Catalent Clinical Trial Material Introduction
11.3.4 Catalent Revenue in Clinical Trial Material Business (2017-2022)
11.3.5 Catalent Recent Developments
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Company Details
11.4.2 Eurofins Scientific Business Overview
11.4.3 Eurofins Scientific Clinical Trial Material Introduction
11.4.4 Eurofins Scientific Revenue in Clinical Trial Material Business (2017-2022)
11.4.5 Eurofins Scientific Recent Developments
11.5 Biocair
11.5.1 Biocair Company Details
11.5.2 Biocair Business Overview
11.5.3 Biocair Clinical Trial Material Introduction
11.5.4 Biocair Revenue in Clinical Trial Material Business (2017-2022)
11.5.5 Biocair Recent Developments
11.6 Almac Group
11.6.1 Almac Group Company Details
11.6.2 Almac Group Business Overview
11.6.3 Almac Group Clinical Trial Material Introduction
11.6.4 Almac Group Revenue in Clinical Trial Material Business (2017-2022)
11.6.5 Almac Group Recent Developments
11.7 Piramal Pharma Solutions
11.7.1 Piramal Pharma Solutions Company Details
11.7.2 Piramal Pharma Solutions Business Overview
11.7.3 Piramal Pharma Solutions Clinical Trial Material Introduction
11.7.4 Piramal Pharma Solutions Revenue in Clinical Trial Material Business (2017-2022)
11.7.5 Piramal Pharma Solutions Recent Developments
11.8 Parexel
11.8.1 Parexel Company Details
11.8.2 Parexel Business Overview
11.8.3 Parexel Clinical Trial Material Introduction
11.8.4 Parexel Revenue in Clinical Trial Material Business (2017-2022)
11.8.5 Parexel Recent Developments
11.9 PRA Health Sciences
11.9.1 PRA Health Sciences Company Details
11.9.2 PRA Health Sciences Business Overview
11.9.3 PRA Health Sciences Clinical Trial Material Introduction
11.9.4 PRA Health Sciences Revenue in Clinical Trial Material Business (2017-2022)
11.9.5 PRA Health Sciences Recent Developments
11.10 PCI Pharma Services
11.10.1 PCI Pharma Services Company Details
11.10.2 PCI Pharma Services Business Overview
11.10.3 PCI Pharma Services Clinical Trial Material Introduction
11.10.4 PCI Pharma Services Revenue in Clinical Trial Material Business (2017-2022)
11.10.5 PCI Pharma Services Recent Developments
11.11 Capsugel
11.11.1 Capsugel Company Details
11.11.2 Capsugel Business Overview
11.11.3 Capsugel Clinical Trial Material Introduction
11.11.4 Capsugel Revenue in Clinical Trial Material Business (2017-2022)
11.11.5 Capsugel Recent Developments
11.12 OCT Group
11.12.1 OCT Group Company Details
11.12.2 OCT Group Business Overview
11.12.3 OCT Group Clinical Trial Material Introduction
11.12.4 OCT Group Revenue in Clinical Trial Material Business (2017-2022)
11.12.5 OCT Group Recent Developments
11.13 Acnos Pharma
11.13.1 Acnos Pharma Company Details
11.13.2 Acnos Pharma Business Overview
11.13.3 Acnos Pharma Clinical Trial Material Introduction
11.13.4 Acnos Pharma Revenue in Clinical Trial Material Business (2017-2022)
11.13.5 Acnos Pharma Recent Developments
11.14 KLIFO
11.14.1 KLIFO Company Details
11.14.2 KLIFO Business Overview
11.14.3 KLIFO Clinical Trial Material Introduction
11.14.4 KLIFO Revenue in Clinical Trial Material Business (2017-2022)
11.14.5 KLIFO Recent Developments
11.15 Ancillare, LP
11.15.1 Ancillare, LP Company Details
11.15.2 Ancillare, LP Business Overview
11.15.3 Ancillare, LP Clinical Trial Material Introduction
11.15.4 Ancillare, LP Revenue in Clinical Trial Material Business (2017-2022)
11.15.5 Ancillare, LP Recent Developments
11.16 ADAllen Pharma
11.16.1 ADAllen Pharma Company Details
11.16.2 ADAllen Pharma Business Overview
11.16.3 ADAllen Pharma Clinical Trial Material Introduction
11.16.4 ADAllen Pharma Revenue in Clinical Trial Material Business (2017-2022)
11.16.5 ADAllen Pharma Recent Developments
11.17 Recipharm
11.17.1 Recipharm Company Details
11.17.2 Recipharm Business Overview
11.17.3 Recipharm Clinical Trial Material Introduction
11.17.4 Recipharm Revenue in Clinical Trial Material Business (2017-2022)
11.17.5 Recipharm Recent Developments
11.18 Movianto
11.18.1 Movianto Company Details
11.18.2 Movianto Business Overview
11.18.3 Movianto Clinical Trial Material Introduction
11.18.4 Movianto Revenue in Clinical Trial Material Business (2017-2022)
11.18.5 Movianto Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer